---
figid: PMC3817019__dddt-7-1315Fig2
figlink: /pmc/articles/PMC3817019/figure/f2-dddt-7-1315/
number: Figure 2
caption: 'An overview of the EGFR pathway and its main downstream effectors, PI3K/AKT
  and KRAS/BRAF/MEK/MERK.Notes: Activated AKT and MEK/MERK can induce cancer cell
  proliferation and invasion. In addition, activated AKT can induce cancer stem cell
  renewal and differentiation. Anti-EGFR mAbs, such as cetuximab or panitumumab, can
  bind EGFR and block its function.Abbreviations: EGFR, epidermal growth factor receptor;
  mAb, monoclonal antibody; CSC, cancer stem cell.'
pmcid: PMC3817019
papertitle: Molecularly targeted drugs for metastatic colorectal cancer.
reftext: Ying-dong Cheng, et al. Drug Des Devel Ther. 2013;7:1315-1322.
pmc_ranked_result_index: '53619'
pathway_score: 0.961587
filename: dddt-7-1315Fig2.jpg
figtitle: 'EGFR pathway and its main downstream effectors, PI3K/AKT and KRAS/BRAF/MEK/MERK.Notes:
  Activated AKT and MEK/MERK can induce cancer cell proliferation and invasion'
year: '2013'
organisms: Homo sapiens
ndex: 13221938-deda-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3817019__dddt-7-1315Fig2.html
  '@type': Dataset
  description: 'An overview of the EGFR pathway and its main downstream effectors,
    PI3K/AKT and KRAS/BRAF/MEK/MERK.Notes: Activated AKT and MEK/MERK can induce cancer
    cell proliferation and invasion. In addition, activated AKT can induce cancer
    stem cell renewal and differentiation. Anti-EGFR mAbs, such as cetuximab or panitumumab,
    can bind EGFR and block its function.Abbreviations: EGFR, epidermal growth factor
    receptor; mAb, monoclonal antibody; CSC, cancer stem cell.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R4
  - MAPK1
  - AKT2
  - PIK3R5
  - AKT1
  - MAP2K2
  - PIK3CD
  - MAP2K1
  - MAPK3
  - EGFR
  - KRAS
  - PIK3CG
  - PIK3CA
  - PIK3R6
  - PIK3R3
  - PIK3CB
  - BRAF
  - AKT3
  - Cancer
  - Lung cancer
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
